Sign in
4

Changes in Ownership

Immunocore Holdings plc Filed Acc 0001955244-26-000002

HEAD OF R&D sold 5,965 shares at $32.35 ($192,968)

  • HEAD OF R&D acquired 11,824 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Berman David M · HEAD OF R&D

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-17 Exercise or conversion : show line 1 in the form +11,824 11,824 D
2026-02-18 Sale : show line 2 in the form −5,965 $32.35 $192,968 5,859 D
Open-market sales · 5,965 sh · avg $32.35 · $192,968

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-17 Exercise or conversion : show line 3 in the form Restricted Share Units −11,824 35,473 D
Loading xslF345X05/form4-02192026_050203.xml…